Learning objectives

After watching this webinar, participants will understand

• the latest adaptations in anticoagulation practices for patients with atrial fibrillation based on 2024 ESC Guideline recommendations;
• the practical management of atrial high-rate episodes (device-detected atrial fibrillation) based on findings from the NOAH-AFNET and ARTESIA trials; and
• the latest scientific evidence regarding the use of direct oral anticoagulants (DOACs) in atrial fibrillation patients with comorbidities.

Needs assessment and expected educational outcome

To provide knowledge about the latest changes in anticoagulation practice from the 2024 ESC Guidelines and to highlight the reasons for these adaptations.

Main topic

• Clinical Skills, Other

Related topics

• Treatment
• Lifestyle Modification
• Antiarrhythmic Drug Treatment
• Cardioversion and Defibrillation
• Catheter Ablation of Arrhythmias
• Clinical
• Atrial Fibrillation (AF)

A dedicated page on Atrial fibrillation is highlighted in the FOCUS edition of November 2024.

For more focused information about this topic, please watch the following webinar:

• Prevention of stroke and thromboembolism in patients with AF: hurdles and optimal decision making (13/11/2024)
• Making better decisions on rhythm control for AF to improve patient symptoms and morbidity (20/11/2024)

This webinar is designed for electrophysiologists specialists but also cardiologists wishing to update their scientific knowledge on the topic. 

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).